Using PET scans to guide targeted radiation for metastatic prostate cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether doing a second PET scan during treatment can help doctors decide if more precise radiation (SABR) should be used on all cancer spots in men with prostate cancer that has spread. It aims to see if this approach can better control the cancer while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with prostate cancer that has spread to a few other parts of the body (between 4 and 20 spots).
- You must be 18 years or older and generally in good health (able to care for yourself).
- You must be scheduled to receive standard hormone therapy (ADT) for your cancer, but not docetaxel chemotherapy at the start.
- You must not have had radiation to any of the targeted cancer spots before.
- Cancer must not be in the esophagus, stomach, intestines, or extremely close to the windpipe.
- You must be willing to use effective birth control during the study and for 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This trial tests whether using a specialized PSMA PET scan to guide radiation can better treat prostate cancer that returns after prostate surgery. It targets the “prostate bed” area with a shorter, stronger radiation schedule (hypofractionated) to control rising PSA levels.
This study looks at how well two different PSMA PET scans work for men with advanced prostate cancer. The scans help doctors see where the cancer is, which can guide treatment decisions and help you and your doctor plan next steps.
This Phase 2 trial tests a radiation-focused approach for people with newly diagnosed (de novo) prostate cancer that has spread to a small number of spots, especially in bone. It aims to see how well the treatment controls the cancer while keeping side effects manageable.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.